Health and wellness firm Hain Celestial's Q1 sales beat estimates

Reuters
2025/11/07
Health and wellness firm Hain Celestial's Q1 sales beat estimates

Overview

  • Hain Celestial fiscal Q1 net sales down 7% yr/yr, slightly beating analyst expectations

  • Adjusted EPS for fiscal Q1 missed analyst expectations

  • Company focused on stabilizing sales and improving profitability through cost discipline

Outlook

  • Hain Celestial aims to stabilize sales and improve profitability in the near term

  • Company expects improved trends in the back half of the year

  • Hain Celestial continues strategic review with Goldman Sachs

Result Drivers

  • SEQUENTIAL SALES IMPROVEMENT - Co reports sequential improvement in organic net sales trends in both North America and International segments

  • COST DISCIPLINE - Reduction in SG&A expenses driven by cost discipline and streamlining actions

  • PRICING INITIATIVES - Co notes benefits from pricing initiatives beginning to build

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Beat

$368 mln

$364.01 mln (8 Analysts)

Q1 Adjusted EPS

Miss

-$0.08

-$0.05 (7 Analysts)

Q1 Adjusted Net Income

Miss

-$7 mln

-$4.50 mln (6 Analysts)

Q1 Net Income

-$21 mln

Q1 Adjusted Gross Margin

19.50%

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the food processing peer group is "buy."

  • Wall Street's median 12-month price target for Hain Celestial Group Inc is $1.84, about 41.7% above its November 6 closing price of $1.07

  • The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 7 three months ago

Press Release: ID:nGNX562Ds2

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10